Advantis Corp., has acquired a 25% stake in US-based pain management and physical therapy company Sequence Therapy, LLC, which sees an exponential growth in revenue, from the current $0.5m a year, with the addition of the app-based revenue.
The acquisition will help Advantis to provide license-based digital application technology and achieve long-lasting results in the treatment of chronic pain.
Madrigal Pharmaceuticals, Inc. has announced a definitive agreement to merge with Synta Pharmaceuticals Corp.
The all-stock transaction will result in the merger of Madrigal with Synta’s wholly-owned subsidiary Saffron Merger Sub, Inc.
The merged entity will focus on developing small-molecule drugs to meet major unmet needs in cardiovascular-metabolic diseases and non-alcoholic steatohepatitis.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData